Balance Sheet
Cash Flow Statement
Amortization of GoodwillAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsCash from RestructuringChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Sales and DivestituresNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Legend Biotech (LEGN) Current Debt: 2020-2022

Historic Current Debt for Legend Biotech (LEGN) over the last 2 years, with Dec 2022 value amounting to $2.5 million.

  • Legend Biotech's Current Debt fell 23.55% to $1.2 million in Q3 2023 from the same period last year, while for Sep 2023 it was -$921,000, marking a year-over-year change of. This contributed to the annual value of $2.5 million for FY2022, which is N/A change from last year.
  • As of FY2022, Legend Biotech's Current Debt stood at $2.5 million, which was up 62,800.00% from -$4,000 recorded in FY2020.
  • Legend Biotech's Current Debt's 5-year high stood at $2.5 million during FY2022, with a 5-year trough of -$4,000 in FY2020.
  • Its 2-year average for Current Debt is $1.3 million, with a median of $1.3 million in 2020.